The Supreme Court rejected Pfizer Inc.’s appeal of a ruling that ordered a retrial on how much punitive damages should be awarded to a woman who developed breast cancer after taking the company’s hormone replacement therapy drugs.
*For more on this story, read the full Reuters article.
